An experimental treatment that uses nanoparticles could be used to target cancer cells within bones.
Scientists from Brigham and Women’s Hospital and Dana-Farber Cancer Institute in the US found that when the nanoparticles, which have been designed to carry anti-cancer drugs, were engineered to home in on bone they slowed the growth of tumours in mice.
The early-stage findings suggest this approach could be used to treat myeloma or breast, prostate and lung cancers, which all have the potential to spread to the bones.
